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ABSTRACT 
Perennial stock-outs of essential medicines are commonplace in the pharmaceutical supply chains of developing 
countries. Stock-outs are mainly attributed to a general lack of collective information sharing in pharmaceutical 
supply chains. In this paper, a  computerised agent-based simulation model concept demonstrator is 
proposed and demonstrated hypothetically as part of a larger drive to establish the value of leveraging 
information sharing in pharmaceutical supply chains with a view to enhance decision-making. The objective of 
this paper is to outline the prerequisite research inputs, design requirements and hypothetical implementation 
of the aforementioned demonstrator. The work reported on in this paper remains a work in progress. 
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1. INTRODUCTION:  
Developing nations carry a considerable burden in terms of life-threatening diseases while the treatment of 
these diseases is significantly complicated by stock-outs and shortages of critical medicines. Stock-outs are 
preventable, but to successfully thwart medicine stock-outs and their damaging consequences demands a major 
overhaul in the management of traditional pharmaceutical supply chains of developing countries. 
 
Recent statistics underline the scale of the global medicine stock-outs dilemma. The Global AIDS Response 
Progress Reporting programme [1], for example, reported that 38 of 108 low- and middle-income countries 
experienced stock-outs of antiretroviral medicines in 2013. In South Africa, a survey conducted in 2015 by the 
Stop Stock-outs Project consortium [2] revealed that approximately one in four health care facilities suffered 
from stock-outs of either antiretroviral or tuberculosis medicines during the three-month period preceding the 
survey. Furthermore, 70% of these stock-outs lasted longer than one month, underlining the supply chain's failure 
to resolve the root causes of stock-outs rapidly. 
 
The consequences of medicine stock-outs are pervasive and are the most severe on the subsequently untreated 
patients. Increased drug resistance, aggravation of, or transmission of, disease and even death are some of the 
harrowing consequences associated with treatment failures [2,3,4]. The impact of stock-outs is particularly harsh 
on impoverished communities in rural areas which depend solely on public health care services. These poor 
patients are forced to pay frequent, and costly, visits to their local health care facilities. Regrettably, if they 
are confronted with stock-outs at these facilities they are turned away and compelled to visit even farther 
facilities, with no guarantee of medicine availability at these facilities either [5]. 
 
The prevailing reasons for pharmaceutical supply chain under-performance in public health sectors include 
fragmented accountability amongst stakeholders [6], superfluous supply chain complexity [6,7], funding 
complexities and inadequacies [6,8,9], as well as insufficient inventory management in the face of information 
shortages and incompetent distribution systems [9,10]. A lack of data capturing and data sharing is, however, 
attributed as one of the predominant obstacles toward pharmaceutical supply chain improvement in developing 
nations [6]. 
 
Developing countries may not have access to the resources required to implement proper information technology 
systems in their pharmaceutical supply chains, but the irrefutable advantages of information sharing are plain 
to see. Sharing supply chain information, such as demand forecasts and inventory levels, across an entire supply 
network allows organisations to proactively plan for disruptive events, instead of reacting (belatedly) to these 
events [11]. As a result, supply chains are able to better balance supply and demand, improve stakeholder 
accountability and ameliorate overall supply chain performance at a reduced cost [6,12,13]. It may be argued 
that information sharing is a suitable starting point for supply chain reform, because it allows organisations to 
collaborate to their mutual benefit. 
 
Initiatives utilising the benefits of information sharing in pharmaceutical supply chains have successfully been 
introduced in some African countries in recent years. A study conducted in 2011 disclosed that at least 60% of 
stock-outs in the Senegalese contraceptive supply chain occurred at warehouses and health care facilities, 
despite stock availability at a national level. These problems sprouted from dismal inventory management and 
poor distribution practices. Upon the implementation of a new system according to which dedicated logisticians 
actively utilise stock data to manage inventory and curb stock-outs, these stock-outs declined to less than 2% 
across 140 health care facilities during the first six months [14].  
 
The SMS for Life programme, established in 2009, is a web-based reporting system that allows health facility 
workers to report stock levels on a weekly basis by means of simple SMS messages. This practice of stock level 
reporting has subsequently alleviated the stock-out predicaments in Kenya and Tanzania and the system is 
geared for roll-out in more African countries [15,16].  
 
The value of mobile technology in respect of information sharing in pharmaceutical supply chains is also 
underlined in South Africa's Stock Visibility Solution (SVS) programme. The SVS is a mobile phone-based reporting 
system that allows dispensing clinic staff to report stock levels at regular intervals [17]. The periodic capturing 
of stock level data allows health care facilities to purposefully manage inventory in a drive to thwart stock-outs. 
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This paper reports on work in progress that is aimed at, amongst others, the utilisation of information sharing in 
pharmaceutical supply chains with a view to enhance decision-making. 
2. PROBLEM DESCRIPTION AND RESEARCH METHODOLOGY 
The problem considered in this research involves the performance of conventional pharmaceutical supply chains 
in developing countries and how these may be improved by the adoption of demand-driven supply chain 
management principles. In particular, the practice of supply chain information sharing is investigated in order 
to establish its potential value in respect of effective inventory management. An agent-based simulation model 
concept demonstrator is developed for use as a test bed to evaluate the efficacy of various inventory 
replenishment policies within a pharmaceutical supply chain context. The simulation model also accommodates 
the possibility of modelling user-specified demand scenarios in order to investigate their influence on the 
effectiveness of inventory replenishment regimes. 
 
The concept demonstrator embraces two modelling paradigms. The first is a descriptive paradigm where the 
model is employed to evaluate the effectiveness of a pre-specified, traditional inventory management policy 
explicitly embedded in the model. The second paradigm, on the other hand, follows a prescriptive approach. 
According to this paradigm, the user does not select a pre-defined policy as in the case of the descriptive 
paradigm. Instead, the simulation model is employed to discover effective inventory management protocols for 
the simulated pharmaceutical supply chain network. In other words, an effective inventory management policy 
is prescribed to the user. 
 
The execution of research toward this paper is segmented into three distinct stages. The first stage comprises a 
brief review of the academic literature relevant to this research project. Thereafter a conceptual framework 
for capturing the structure of a pharmaceutical supply chain network in a format suitable for use in a simulation 
modelling environment is established. Finally, a hypothetical example of applying the proposed simulation model 
is proffered in the third and final stage.  
3. LITERATURE REVIEW 
The literature review in this section consists of four disparate parts, namely a review of the notion of demand-
driven supply chain management (in §3.1), a review of the various basic concepts in inventory management (in 
§3.2), a brief overview of the concepts of self-organisation and emergence (in §3.3) and finally, a review of the 
machine learning paradigm of reinforcement learning (in §3.4). 
3.1 Demand-driven supply chain management 
A common denominator in the traditional management of supply chains is an emphasis placed on the activities 
involved with the downstream movement of commodities along a supply chain [18]. Organisations will, for 
example, streamline their production processes and distribution operations in order to improve the efficiency 
with which goods are moved downstream in a supply chain. Despite acknowledging the importance of these 
downstream management activities, advocates of the so-called demand chain management (DCM) notion suggest 
that the focus of this traditional approach is misplaced. DCM is a relatively new concept supporting the notion 
that end user demand should drive the upstream processes (such as manufacturing and distribution) in a supply 
chain [18]. As such, the end user is considered as the starting point in a supply chain as opposed to being viewed 
as the final destination. This particular school of thought arises from the idea that a supply chain ultimately 
serves to fulfil the needs of the end user. Although products flow downstream toward the end user in a supply 
chain, it is the end user’s demand that should govern the nature of the upstream activities. 
 
Fisher [19] proposed that any supply chain performs two distinct functions. The first is the physical function 
which embodies the physical transformation of raw materials to finished products, and the movement of these 
goods along a supply chain. The physical function determines a supply chain's efficiency. Manufacturing, delivery 
and inventory storage outlays are classified as incurring physical costs since they are part of the physical 
function. The second function is the market mediation function and its purpose is to ensure that customer 
demand is successfully satisfied. Market mediation costs are incurred when supply exceeds demand, or the other 
way around. In the case of oversupply, excessive stocks may be sold at a loss or even discarded in the case of 
perishables. Undersupply of stock, on the other hand, reflects lost sales opportunities. In other words, the 
market mediation function embodies the idea that neither a surplus nor a shortage of stock is desirable in a 
supply chain. 
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Fisher furthermore suggested that organisations may prioritise one function at the expense of the other. An 
organisation subject to predictable demand can, for example, deliberately plan to avoid both a surplus of stock 
as well as a shortage of stock. Such a position enables a firm to devote its attention to enhancing supply chain 
efficiency because the market mediation costs are not considered as significant. Organisations faced with 
unpredictable demand, on the other hand, typically prioritise market mediation costs over physical costs, 
because they prioritise customer satisfaction irrespective of their attained level of supply chain efficiency. 
 
De Treville et al. [20] subsequently defined a demand chain as a supply chain in which the market mediation 
function predominates a supply chain’s function to optimise its physical efficiency (the physical function). The 
adoption of a demand chain approach may seem suitable for a pharmaceutical supply chain because the need 
to successfully fulfil patient demand is of paramount importance. Pharmaceutical supply chains are, in fact, 
compelled to pursue a patient service level of 100% because failure to do so would signify the occurrence of 
stock-outs [21]. Organisations in pharmaceutical supply chains may, however, pursue conflicting objectives. 
Consider a primary health care facility, such as a clinic, which seeks to minimise medicine stock-outs so as to 
fully satisfy patient demand. A drug manufacturer upstream, on the other hand, may solely pursue profit 
maximisation with little regard for the downstream clinic’s service level target. This example illustrates that a 
progression from a conventional pharmaceutical supply chain to a pharmaceutical demand chain which prioritises 
market mediation may not be as simple as it would seem at first.  
 
The practice of information sharing is a powerful enabler of demand-driven supply chain management because 
it allows organisations to better understand customer demand and to collaborate effectively. The concept of 
information sharing, also called supply chain visibility, refers to the degree according to which supply chain 
organisations share information that is pivotal to their own activities and which they consider to be of mutual 
benefit to themselves and other firms in the supply chain [22]. Inventory levels, demand forecasts, order tracking 
and sales data are examples of information shared in supply chains in order to enhance their collective 
performance [23]. In the case of a sudden disease outbreak, for example, patient demand for a particular drug 
may increase considerably over a short period of time. If health care facilities do not carry enough stock to fulfil 
this increased demand, they set off a reverberating chain of belated, large orders along the supply chain.  If the 
rapid demand increase is, however, made known to upstream facilities promptly through information sharing, 
they can increase their operations accordingly in anticipation of larger orders. 
3.2 Inventory replenishment 
A significant trade-off faced by inventory managers during their decision-making processes is the trade-off 
between supply chain responsiveness and efficiency [24]. Carrying large inventories and shortening lead times 
generally make a supply chain more responsive. The increased responsiveness is, however, traded for significant 
inventory holding costs and large transport costs, respectively [24]. 
 
Inventory replenishment policies are typically employed by inventory managers to determine reorder points and 
reorder quantities. Simchi-Levi et al. [25] identified six supply chain variables that play a role in the formulation 
of an inventory replenishment policy. Customer demand is arguably the most significant factor because 
organisations ultimately strive to fulfil their customers’ demand. Secondly, ordering costs and inventory holding 
costs are of obvious financial importance. And to ensure the timely receipt of ordered goods, the reorder point 
should be informed by the replenishment lead time, which may not be deterministic. Furthermore, the order 
quantity may be based on the current inventory level of the product in question. Additionally, the length of the 
planning period shapes the scope and the nature of inventory management decisions. Finally, the service level 
target may be a determinant of the reorder point and the reorder quantity. 
 
The dynamic nature of supply chains suggests that the parameters of an inventory replenishment policy should 
be informed by the current state of the supply chain environment with a view to making better decisions. In 
other words, inventory replenishment protocols should not be too rigid, for otherwise they may fail in the face 
of changes in the supply chain environment. Owing to the large degree of variability and uncertainty in a supply 
chain, the inventory management process remains an intricately complex task. 
3.3 Self-organisation and emergence 
The concepts of self-organisation and emergence are reviewed in order to explore their potential application to 
inventory management protocols in pharmaceutical supply chains. 
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De Wolf and Holvoet [26] describe self-organisation as a continuous process in which coordinated organisation 
manifests itself through the independent behaviour of systems, without any control instructions being imposed 
from outside the system. ‘Organisation’ here refers to the presence of a so-called ‘structure’ that can be of a 
spatial, temporal or functional nature. Although a self-organising process is void of external control, it does not 
preclude data inputs from outside the system. A fundamental property of self-organising systems is that they 
are considered extremely robust and adaptable because they can reproduce ‘organisation’ in the face of 
environmental changes [26,27]. 
 
The presence of self-organisation may give rise to the related phenomenon of emergence. Emergence 
materialises in a system when the local interactions between its individual constituents culminate at a higher 
level in the development of a structure (called ‘coherent emergents’) that is not explicitly represented at a 
lower level [26,28]. An example of self-organisation and emergence in nature is illustrated in Figure 1. When a 
colony of ants arrive at a gap in their path, they often use their bodies to build a living bridge without any 
external supervision or instructions. Each ant follows two simple rules. First, it slows down as it reaches the gap 
and secondly, it freezes when it feels another ant walking over it. The ants continue in this fashion until they 
have successfully bridged the gap. Through the ants’ self-organising behaviour, a living bridge emerges. The 
bridge may be classified as an emergent because no individual ant is representative of the bridge. The bridge is 
only formed at a higher level through the local interactions between the ants at a lower level. 
 
 
Figure 1: A living bridge emerges from the self-organising behaviour of ants [29,30]. 
It may be argued that effective, externally coordinated inventory management in a pharmaceutical supply chain 
is extremely difficult, or even impossible, given the myriad of supply chain variables that influence inventory 
management decisions. Self-organisation (a process void of external control) is therefore explored as an 
alternative means of coordinating inventory management. A self-organising supply chain, by implication, is void 
of any form of centralised control and each facility manages its own inventory exclusively. In this research 
project, we investigate the conjecture that local coordination between facilities may lead to the emergence of 
a greater structure where the global supply chain functions as a coordinated system in respect of inventory 
management. 
 
Consider a simple example of a self-organising pharmaceutical supply chain in which each facility in the chain 
‘organises’ itself with a view to prevent stock-outs locally. These facilities, in other words, are autonomous and 
actively manage their own inventory in pursuit of an ‘organisation’ in which stock-outs are prevented. 
Additionally, in an information sharing supply chain, these facilities may utilise the available information to 
inform their inventory management decisions accordingly. There is, however, no explicit coordination between 
the facilities in the supply chain. If a storage depot is, for example, perturbed by a drastic demand increase, 
the facility may ‘reorganise’ itself by increasing its order quantities. Emergence may subsequently occur in the 
supply chain as a set of management policies prescribing reorder points and reorder quantities in pursuit of 
effective inventory management. 
3.4 Reinforcement learning 
Reinforcement learning is a branch of machine learning where a learning agent learns behaviour in an 
environment through interaction with the environment [31]. The premise of reinforcement learning rests on the 
idea that if a particular action yields desirable results, the inclination to repeat the same action is reinforced 
[32]. This closely relates to the learning process followed by humans and animals. A new-born elephant, for 
example, tries many strategies and fails often before it can stand upright. Over time, the baby elephant learns 
477
 
SAIIE29 Proceedings, 24th – 26th of October 2018, Spier, Stellenbosch, South Africa © 2018 SAIIE 
 
 
 
3633-6 
 
 
 
to avoid the actions that caused it to fall down and it hones the skills that proved more fruitful in pursuit of its 
goal to stand upright.  
 
A fundamental characteristic of reinforcement learning is that a learning agent can evaluate the desirability of 
its actions according to a numerical reward signal, but it is not told which actions to take in order to improve 
its performance [33,34]. The reward signal is expressed in terms of a pre-specified goal that is pursed by the 
agent. Hence, a learning agent has to attempt many different strategies by itself in order to learn what behaviour 
maximises its reward signal. This learning process can informally be described as learning through trial-and-
error. The new-born elephant, for example, is said to learn through trial-and-error which strategies prove to be 
more successful.  
 
The reinforcement learning approach is commonly described in terms of an agent and an environment [33,34]. 
The agent is the learning actor which interacts with its environment in order to learn about the environment. A 
state describes the situation in the environment at any given time instant. At discrete time steps, the agent is 
presented with an array of actions from which it can choose. The selected action influences the environment 
and the environment provides feedback to the agent in the form of a reward signal and by transitioning into a 
new state. The reward signal is employed to evaluate the immediate reward received for the selected action. 
Notably, the agent’s objective in reinforcement learning is to maximise its cumulative reward and, occasionally, 
these rewards may be significantly delayed [33,34]. The reinforcement learning cycle repeats itself many times 
and, over time, the agent learns to map different situations to particular actions that yield desirable results. A 
schematic of this learning paradigm is shown in Figure 2. The outcome of a reinforcement learning process may 
be described as a look-up table [33]. This table maps all possible environment states to appropriate actions that 
have proved to maximise the agent’s reward during the learning process. 
 
 
Figure 2: The reinforcement learning cycle (adapted from [33]). 
Reinforcement learning forms the cornerstone of the prescriptive paradigm of the proposed concept 
demonstrator, as discussed in §1. Each facility type in a pharmaceutical supply chain (i.e. manufacturer, 
warehouse, clinic, etc.), is trained as a reinforcement learner. A unique look-up table of state-action pairs is 
subsequently generated for each facility type that can be utilised by the facility to inform decision-making on a 
daily basis aimed at improving performance indicators aligned with various management objectives. 
4. CONCEPTUAL INPUT FRAMEWORK FOR PHARMACEUTICAL SUPPLY CHAIN MODELLING 
As discussed in §1, an agent-based pharmaceutical supply chain simulation model is put forward in this paper. 
The simulation model follows a generic design so as to enhance its flexibility and potential value for decision 
makers in pharmaceutical supply chains. According to this generic design, the simulation model receives a user-
specified supply chain structure as input. This input structure, called an input framework, should sufficiently 
capture the level of abstraction required to model a pharmaceutical supply chain mathematically, as per the 
purposes of this research. This section is devoted to a description of the conceptual design of such an input 
framework. This framework is not, however, exhaustive, but simply serves as a point of departure for the 
development of a comprehensive, well-rounded input framework. 
 
The input framework should capture facility-specific information, product-specific information, as well as 
inventory management parameters and product demand profiles. A list of attributes that captures the high-
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level, facility-specific information is shown in Table 1. This information set describes the size of the supply chain 
network and its prevailing facility types. 
Table 1: Facility-specific information provided as input. 
Attribute Description 
Facility name Common name used to identify the facility 
Location Spatial information 
Facility type The nature of a facility’s operations. For example: Manufacturer, 
storage facility, hospital, clinic, etc. 
Tier Specification of the relevant echelon in the supply chain 
Storage capacity The facility’s total storage capacity for the purposes of the simulation 
 
The simulation model’s generic design allows for the inclusion of user-specified pharmaceutical products. The 
product-specific information required extends only to the name of the product and its shelf life, as shown in 
Table 2.  
Table 2: Product-specific information provided as input. 
Attribute Description 
Product name Commonly used product name 
Shelf life (if perishable) Shelf life duration (from date of manufacture) 
 
A traditional from-to matrix can be used to capture the connections between facilities in a supply chain. These 
connections indicate the flow of goods between facilities. The matrix is of size 𝑛 × 𝑛 where 𝑛 denotes the total 
number of facilities in the supply chain. If product units flow from facility 𝑖 to facility 𝑗, the (𝑖, 𝑗)th entry in the 
matrix adopts a value of 1, or a value of 0 otherwise. The facility names are obtained from Table 1. An example 
of a from-to matrix for a supply chain comprising three facilities is shown in Table 3. Facility A, for example, 
distributes goods to Facilities B and C. Facility B, on the other hand, distributes only to Facility C and Facility 
C, in turn, does not distribute any inventory to other facilities.  
Table 3: An example of a 𝟑 × 𝟑 from-to matrix provided as input. 
 Facility A Facility B Facility C 
Facility A - 1 1 
Facility B 0 - 1 
Facility C 0 0 - 
 
As discussed in §1, the descriptive paradigm of the concept demonstrator allows the user to evaluate the 
performance of pre-specified inventory replenishment policies. In order to facilitate this paradigm, the user is 
required to specify the parameters of these policies as part of the input framework. The relevant inventory 
management parameters required to model the inventory management processes are presented in Table 4. 
According to the table, the user can specify parameters for a continuous review policy, or for a periodic review 
policy. Table 4 may, of course, be extended to include more inventory management policies. 
Table 4: Inventory management parameters provided as input. 
Attribute Description 
Ordering facility  Facility name from Table 1 
Product Product name from Table 2 
Starting inventory Product quantities available at the start of the simulation 
Minimum order quantity If applicable 
Maximum order quantity If applicable 
Reorder point For a continuous review policy 
Reorder quantity For a continuous review policy 
Review interval For a periodic review policy 
Order-up-to level For a periodic review policy 
Lead time (days) As a function of order size, may be stochastic 
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In order to model the manufacturing operations of manufacturers in the supply chain, the production process 
characteristics have to be captured in the format as shown in Table 5. This information is applicable to 
manufacturers only. 
Table 5: Manufacturing information provided as input. 
Attribute Description 
Manufacturer Facility name from Table 1 
Product Product name from Table 2 
Starting inventory Product quantities available at the start of the simulation 
Production trigger Signal that triggers the initiation of the production process 
Production rate Expressed in number of batches per time unit 
Batch size The number of units in a single batch 
 
Finally, forecasted demand data and actual demand data for the simulation period can be provided as input. 
Users may provide either synthesised data or actual data as input. The nature of the demand data required is 
elucidated in Table 6. 
Table 6: Demand data provided as input. 
Attribute Description 
Facility Name from Table 1 
Product Product name from Table 2 
Actual demand Daily demand for each simulated day 
Forecasted demand Daily forecasted demand for each simulated day 
 
A potential implementation of this input framework is demonstrated by means of a hypothetical example in the 
following section. 
5. HYPOTHETICAL EXAMPLE 
The objective of this section is to integrate the salient elements of the literature review in §3 with the input 
framework of §4 in order to demonstrate how it may be applied in practice by means of a small hypothetical 
example. 
 
Consider a simple pharmaceutical supply chain comprising a single manufacturer, a single warehouse and two 
clinics. The supply chain facilitates the flow of Painstill drugs from the manufacturer to the clinics, via the 
warehouse. Currently all four facilities in the supply chain employ traditional continuous review replenishment 
policies. 
 
The Painstill supply chain has suffered from large-scale stock-outs in recent months and it has been decided to 
investigate avenues for improving its inventory management practices. In particular, the value of supply chain 
information sharing is of interest and how it may inform effective inventory management in the supply chain 
with a view to minimise stock-outs. The management team has turned to the simulation model proposed in this 
paper to support their decision-making processes. After populating the input framework of §4, the management 
team decides to employ both the descriptive and prescriptive modelling paradigms. 
 
Descriptive paradigm 
According to the descriptive paradigm, a pre-defined replenishment policy is selected for each facility from a 
list of possible policies. The management team decides to continue with a continuous review policy for each 
facility. Using the simulation model, the management team can now experiment with different parameter values 
(reorder points and reorder quantities) for each facility in order to determine how they may improve the 
effectiveness of the continuous review policies. The operation of the supply chain is now simulated according to 
the specified parameters. The movement of Painstill units through the supply chain, and charts denoting 
information such as inventory levels may be displayed during the simulation model execution. At the end of the 
simulation run, a set of key performance indicator values are provided as output. Examples of suitable key 
performance indicators may include attained service levels, the number of stock-outs per facility, the average 
stock-out duration per facility, as well as the procurement costs and inventory holding costs incurred by each 
facility. An example of a graphic denoting a facility’s stock level data and demand data are shown in Figure 3. 
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Suppose that the sudden demand increase observed at day 111 is attributed to an unexpected disease outbreak. 
It is evident from the stock level graph that the facility carried enough stock to fulfil the increased demand 
initially. The stock level has, however, declined to a minimum of 140 units on day 122. The relevant decision-
makers may therefore infer that it is best to increase the facility’s order quantities in the face of a similar 
demand increase in order to negate the possibility of stock-outs. 
    
 
Figure 3: A graph of a facility’s stock level over time (left) and the same facility’s corresponding demand 
over time (right). A sudden demand increase is observed at day 111 due to a sudden disease outbreak. 
Prescriptive paradigm 
The prescriptive paradigm integrates the concepts of demand-driven supply chain management, self-
organisation and reinforcement learning as a means to prescribe effective replenishment policies for the 
modelled supply chain network. The output of this paradigm is therefore a set of key performance indicator 
values, as well as a set of policies prescribing reorder points and reorder quantities for each facility. ‘Self-
organisation’ in this context means that each facility makes its own inventory decisions, as alluded to in §3.3. 
The prescriptive paradigm lends itself to a large degree of scalability because of the supply chain’s self-
organising property. The effects of the local interactions between facilities may ripple outward until a form of 
organisation is achieved and maintained across the entire supply network. The size of the supply chain therefore 
has little influence on the model complexity. 
 
The user should explicitly define the level and degree of information that may be shared and used by other 
facilities in order to facilitate their decision-making processes. The management team can, for example, explore 
the effect of sharing both clinics’ stock level data with the warehouse. This level of visibility may presumably 
allow the warehouse to increase its inventory proactively should the clinics’ stock levels start to decline rapidly 
in response to a sudden demand increase. The management team can, however, also investigate the value of 
sharing the clinics’ stock level data with both the warehouse and the manufacturer, provided that the 
manufacturer also has visibility over the warehouse’s stock level data. Intuitively, it may be argued that the 
increased level of supply chain visibility may be accompanied by improved overall supply chain performance. 
Comparing these two scenarios at the hand of the simulation model may elucidate whether the larger investment 
in information technology required for the second scenario is, in fact, justified in respect of the simulation 
results. It may, for example, be that the increased level of information sharing of the second scenario does not 
significantly improve on the effectiveness delivered in the first scenario. The simulation model may prove 
extremely useful for similar comparison analyses. 
 
Once the information sharing structure has been configured in the model, reinforcement learning may be applied 
as a mechanism to discover self-organising replenishment heuristics. Since facilities of the same type share 
common operational characteristics, all the instances of a particular type of facility can use the same look-up 
table. Therefore, only one agent can represent each facility type, be trained and only generate one look-up 
table per agent. For the Painstill supply chain, a manufacturer agent, a warehouse agent and a clinic agent have 
to be trained as reinforcement learners, respectively. Notably, both clinics use the single look-up table 
generated by the clinic agent. The learning process is expected to be computationally expensive, but this is an 
offline process which is executed a priori. 
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The respective reward functions of these agents may be specified by the user. A typical reward function should 
reward desirable actions, such as the successful fulfilment of customer demand. For undesirable scenarios, such 
as the occurrence of stock-outs, product expirations or large inventory carrying costs, agent punishment should 
result in the form of a negative reward signal. Notably, the reward function need not be particular to one agent, 
but rewards may be shared amongst agents. Rewards may be shared between a warehouse and a clinic (the 
clinic orders from this warehouse), for example, in an attempt to enhance their collective performance. 
 
A state should describe all the information that is visible to a learning agent at any given time instant during 
the learning process. The state may include a number of dimensions, such as the agent’s current inventory level 
and its forecasted demand. If, for example, the Painstill manufacturer has visibility over the warehouse’s stock 
level, the manufacturer agent’s state space would include the warehouse’s stock level data. In other words, the 
size of an agent’s state should be informed by the level and degree of information sharing. At discrete time 
steps, each agent should decide whether to place a new order for Painstill drugs, or not. If the agent decides to 
order, the order quantity should also be selected. The simulation model should replicate many possible scenarios 
in the supply chain and the reinforcement learning algorithm should experiment with different order strategies 
during the process. Over time, each agent learns which inventory management decisions (actions) yield the most 
reward within a particular situation (state), and these are documented in a look-up table. In other words, each 
agent learns when to place a new order and how much to order, given a certain state. 
 
The management team may use the results of both the descriptive and prescriptive paradigms to provide them 
with decision support in pursuit of their drive to improve the efficiency of the Painstill supply chain. The 
simulation results may, for example, provide insight as to which facilities suffer the most from stock-outs and 
why under different demand scenarios. The management team can also identify those facilities at which product 
expirations occur most frequently and subsequently learn which replenishment policies may prevent them. 
Additionally, cost-related key performance indicators may provide an indication of the financial feasibility of a 
particular policy. Finally, the prescriptive paradigm may elucidate which type of information should be shared, 
and with whom, for the best outcome in respect of the management team’s various objectives. 
6. CONCLUSION 
The objective of this paper was fourfold. First, to establish the background context of this research project as 
the inventory management methodologies of demand-driven pharmaceutical supply chains. Secondly, to provide 
a brief overview of the relevant academic literature which serves as a basis for the work conducted in this 
research. Thereafter, a preliminary, conceptual input framework for pharmaceutical supply chain modelling was 
developed. Finally, the potential use of the planned proposed concept demonstrator was illustrated by means 
of a hypothetical example. It is important to stress that the work described in this paper is not concluded. This 
paper serves as a prelude to a larger research project in which the value of self-organisation and information 
sharing in the pharmaceutical supply chains of developing countries is explored and quantified. It is 
acknowledged that these concepts may not be readily compatible with existing supply chain infrastructure and 
resources in these countries. This research, however, aims to elucidate whether self-organisation is a suitable 
instrument for pharmaceutical supply chain reform. 
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